|
[1] Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340:115-126. [2] Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973; 180:1332-1339. [3] Mehrabian M, Wen PZ, Fisler J, Davis RC, Lusis AJ. Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J Clin Invest. 1998; 101:2485-2496. [4] Lusis AJ, Weinreb A, Drake TA. In: Textbook of Cardiovascular Medicine (ed. Topol, E. J.) Lippincott-Raven, Philadelphia. 1998:2389-2413. [5] Libby P. The vascular biology of atherosclerosis. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, PA: W. B. Saunders Co., 2001:995-1009. [6] Libby P. Changing concepts of atherogenesis. J Intern Med. 2000; 247:349-358. [7] Plutzky J. The vascular biology of atherosclerosis. Am J Med. 2003; 115:55S-61S. [8] Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol. 1997; 20:3-10. [9] Orford JL, Selwyn AP, Ganz P. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol. 2000; 86(suppl):6H-11H. [10] Shanahan CM, Weissberg PL. Smooth muscle cell phenotypes in atherosclerotic lesions. Curr Opin Lipidol. 1999; 10:507-513. [11] Schmitz G, Herr AS, Rothe G. T-lymphocytes and monocytes in atherogenesis. Herz. 1998; 23:168-177. [12] Eriksson EE, Xie X, Werr J, Thoren P, Lindbom L. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J. 2001; 15:1149-1157. [13] Barnathan ES, Raghunath, PN, Tomaszewski JE, Ganz T, Cines DB, Higazi AA. Immunohistochemical localization of defensin in human coronary vessels. Am J Pathol. 1997; 150:1009-1020. [14] Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem. 1996; 27:8837-8842. [15] Squier MK, Sehnert AJ, Cohen JJ. Apoptosis in leukocytes. J Leukoc Biol. 1995; 57:2-10. [16] Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999; 282:2035-2042. [17] Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990; 66:1045-1066. [18] Berger SA, Jou LD. Flows in stenotic vessels. Annu Rev Fluid Mech. 2000; 32:347-382. [19] Chiu JJ, Chen CN, Lee PL, Yang CT, Chuang HS, Chien S, Usami S. Analysis of the effect of disturbed flow on monocytic adhesion to endothelial cells. J Biomech. 2003; 36:1883-1895. [20] Toborek M, Kaiser S. Endothelial cell functions: Relationship to atherogenesis. Basic Res Cardiol. 1999; 94:295-314. [21] Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91:3527-3561 [22] Davies PF. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Lab Invest. 1986; 55:5-24. [23] Spagnoli LG, Villaschi S, Neri L, Palmieri G. Gap junctions in myo-endothelial bridges of rabbit carotid arteries. Experientia. 1982; 38:124-125. [24] Heydarkhan-Hagvall S, Helenius G, Johansson BR, Li JY, Mattsson E, Risberg B. Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors. J Cell Biochem. 2003; 89:1250-1259. [25] Xu CB, Falke P, Stavenow L. Interactions between cultured bovine arterial smooth muscle cells and endothelial cells; studies on the release of growth inhibiting and growth stimulating factors. Artery. 1990; 17:297-310. [26] Folkman J, D’Amore PA. Blood vessel formation: What is its molecular basis? Cell. 1996; 87:1153-1155. [27] Vernon SM, Campos MJ, Haystead T, Thompson MM, DiCorleto PE, Owens GK. Endothelial cell conditioned medium down-regulates smooth muscle contractile protein expression. Am J Physiol. 1997; 272:C582-C591. [28] Vanhoutte P. Endothelium and control of vascular function: State of the art lecture. Hypertension. 1989; 13:658-667. [29] Akopov S. Stable analogues of prostacyclin and thromboxane A display contradictory influences on atherosclerotic properties of cells cultured from human aorta: The effect of calcium antagonists. Atherosclerosis. 1988; 72:245-248. [30] Thomae KR, Nakayama DK, Billiar TR, Simmons RL, Pitt BR, Davies P. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res. 1995; 59:337-343. [31] Janakidevi K, Fisher MA, Del Vecchio PJ, Tiruppathi C, Figge J, Malik AB. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol. 1992; 263:C1295-C1301. [32] Yoshida H, Nakamura M, Makita S, Hiramori K. Paracrine effect of human vascular endothelial cells on human vascular smooth muscle cell proliferation: Transmembrane co-culture method. Heart Vessels. 1996; 11:229-233. [33] Chien S, Li S, Shyy YJ. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension. 1998; 31; 162-169. [34] Reidy MA, Bowyer DE. Scanning electron microscopy of arteries. The morphology of aortic endothelium in haemodynamically stressed areas associated with branches. Atherosclerosis. 1977; 26:181-194. [35] Levesque MJ, Liepsch D, Moravec S, Nerem RM. Correlation of endothelial cell shape and wall shear stress in a stenosed dog aorta. Arteriosclerosis. 1986; 6:220-229. [36] Okano M, Yoshida Y. Endothelial cell morphometry of atherosclerotic lesions and flow profiles at aortic bifurcations in cholesterol fed rabbits. J Biomech Eng. 1992; 114:301-308. [37] Davies PF, Remuzzi A, Gordon EJ, Dewey CF Jr, Gimbrone MA Jr. Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci U S A. 1986; 83:2114-2117. [38] DePaola N, Gimbrone MA Jr, Davies PF, Dewey CF Jr. Vascular endothelium responds to fluid shear stress gradients. Arterioscler Thromb. 1992; 12:1254-1257. [39] Nerem RM. Vascular fluid mechanics, the arterial wall, and atherosclerosis. J Biomech Eng. 1992; 114:274-282. [40] Hill GE, Whitten CW. The role of the vascular endothelium in inflammatory syndromes, atherogenesis, and the propagation of disease. J Cardiothorac Vasc Anesth. 1997; 11: 316-21 [41] Hirst SJ, Twort CH, Lee TH. Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am J Respir Cell Mol Biol. 2000; 23:335-344. [42] Chamley-Campbell JH, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979; 59:1-61. [43] Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol. 1988; 107:307-319. [44] Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84:767-801. [45] Gosens R, Schaafsma D, Meurs H, Zaagsma J, Nelemans SA. Role of Rho- kinase in maintaining airway smooth muscle contractile phenotype. Eur J Pharmacol. 2004, 483:71-78. [46] Sobue K, Hayachi KI, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem. 1999; 190:105-118. [47] Solway J, Forsythe SM, Halayko AJ, Vieira JE, Mercado-camoretti B. Transcriptional regulation of smooth muscle-specific genes. Am J Respir Crit Care Med. 1998; 158:S100-S108. [48] Raines EW, Ferri N. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res. 2005; 46:1081-1082. [49] Hughes AD, Clunn GF, Refson J, Demoliou-Mason C. Platelet-derived growth factor: actions and mechanisms in vascular smooth muscle. Gen Pharmacol. 1996; 7:1079-1089. [50] Majack RA, Grieshaber NA, Cook CL, Weiser MC, McFall RC, Grieshaber SS, Reidy MA, Reilly CF. Smooth muscle cells isolated from the neointima after vascular injury exhibit altered responses to platelet-derived growth factor and other stimuli. J Cell Physiol. 1996; 167:106-112. [51] Bourcier T, Dockter M, Hassid A. Synergistic interaction of IL-1 and growth factors in primary cultures of rat aortic smooth muscle cells. J Cell Physiol. 1995; 164:644-657. [52] Ley K. Molecular mechanisms of leucocyte rolling and adhesion to microvascular endothelium. Eur Heart J. 1993; 14:68-73. [53] Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003; 170:191-203. [54] Bursill CA, Channon KM, Greaves DR. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr Opin Lipidol. 2004; 15:145-149. [55] Bendall L. Chemokines and their receptors in disease. Histol Histopathol. 2005; 20:907-926. [56] Xu J, Wang F, Van KA, Herzmark P, Straight A, Kelly K, Takuwa Y, Sugimoto N, Mitchison T, Bourne HR. Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell. 2003; 114:201-214. [57] Wiener OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, Bourne HR. A PtdInsP3- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol. 2002; 4:509 -512. [58] Skilbeck C, Westwood SM, Walker PG, David T, Nash GB. Population of the vessel wall by leukocytes binding to P-selectin in a model of disturbed arterial flow. Arterioscler Thromb Vasc Biol. 2001; 21:1294-300. [59] Pritchard WF, Davies PF, Derafshi Z, Polacek DC, Tsa R, Dull RO, Jones SA, Giddens DP. Effects of wall shear stress and fluid recirculation on the localisation of circulating monocytes in a three-dimensional flow model. J Biomech. 1995; 28:1459-1469. [60] Barber KM, Pinero A, Truskey GA. Effects of recirculating flow on U-937 cell adhesion to human umbilical vein endothelial cells. Am J Physiol. 1998; 257:H591-H599. [61] Cuvelier SL, Patel KD. Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. J Exp Med. 2001; 194:1699-1709. [62] Weber KS, von Hundelshausen P, Clark-Lewis I, Weber PC, Weber C. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol. 1999; 29:700-712. [63] Kitayama J, Hidemura A, Saito H, Nagawa H. Shear stress affects migration behavior of polymorphonuclear cells arrested on endothelium. Cell Immunol. 2000; 203:39-46. [64] Li S, Lao J, Chen BP, Li YS, Zhao Y, Chu J, Chen KD, Tsou TC, Peck K, Chien S. Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J. 2003; 17:97-99. [65] Gimbrone MA Jr. Culture of vascular endothelium. In: Spact TH, ed. Progress in Hemostasis and Thrombosis. Vol. 3. New York: Grune and Stratton; 1976:1-28. [66] Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 968; 97:77-89. [67] Oppenheimer-Marks N, Davis LS, Lipsky PE. Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J Immunol. 1990; 145:140-148. [68] Tridandapani S, Lyden TW, Smith JL, Carter JE, Coggeshall KM, Anderson CL. The adapter protein LAT enhances fcgamma receptor-mediated signal transduction in myeloid cells. J Biol Chem. 2000; 275:20480-20487. [69] Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM, Hemmings BA. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 1997; 272:31515-31524. [70] Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996; 15:6541-6551. [71] Alvarez B, Garrido E, Garcia-Sanz JA, Carrera AC. Phosphoinositide 3-kinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate. J Biol Chem. 2003; 278:26466-26473. [72] Panayotou G, Bax B, Gout I, Federwisch M, Wroblowski B, Dhand R, Fry MJ, Blundell TL, Wollmer A, Waterfield MD. Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes. EMBO J. 1992; 11:4261-4272. [73] Rainger GE, Nash GB. Cellular pathology of atherosclerosis: smooth muscle cells prime co-cultured endothelial cells for enhanced leukocyte adhesion. Circ Res. 2001; 88:615-622. [74] Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996; 87:1069-1078. [75] Raines EW, Koyama H, Carragher NO. The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF. Ann N Y Acad Sci. 2000; 902:39-52. [76] Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004; 15:197-204. [77] Waters CM, Connell MC, Pyne S, Pyne NJ. c-Src is involved in regulating signal transmission from PDGF-beta receptor-GPCR(s) complexes in mammalian cells. Cell Signal. 2005; 17:263-277. [78] Jo M, Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem. 2000; 275:8806-8811. [79] Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989; 243:393-396. [80] Ikeda U, Ikeda M, Oohara T, Kano S, Yaginuma T. Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis. 1990; 84:183-188. [81] Chiarugi P, Cirri P, Taddei ML, Talini D, Doria L, Fiaschi T, Buricchi F, Giannoni E, Camici G, Raugei G, Ramponi G. New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases. J Cell Sci. 2002; 115:2219-2232. [82] Guy GR, Cairns J, Ng SB, Tan YH. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J Biol Chem. 1993; 268:2141-2148. [83] Karino T, Goldsmith HL. Adhesion of human platelets to collagen on the walls distal to a tubular expansion. Microvasc Res. 1979; 17:238-262. [84] Hinds MT, Park YJ, Jones SA, Giddens DP, Alevriadou BR. Local hemodynamics affect monocytic cell adhesion to a three-dimensional flow model coated with E-selectin. J Biomech. 2001; 34:95-103. [85] Truskey GA, Barker KM, Rober KM, Oliver LA, Combs MP. Characterization of a sudden expansion flow chamber to study the response of endothelium to flow recirculation. J Biomech Eng. 1995; 117:203-210. [86] Chiu JJ, Wang DL, Chien S, Skalak R, Usami S. Effects of disturbed flow on endothelial cells. J Biomech Eng. 1998; 120:2-8. [87] Skilbeck C, Westwood SM, Walker PG, David T, Nash GB. Dependence of adhesive behavior of neutrophils on local fluid dynamics in a region with recirculating flow. Biorheology. 2001; 38:213-227. [88] Macagno EO, Hung TK. Computational and experimental study of a captive annular eddy. J Fluid Mech. 1967; 28:43-64. [89] Munn LL, Melder RJ, Jain RK. Analysis of cell flux in the parallel plate flow chamber: implications for cell capture studies. Biophys J. 1994; 67:889-895. [90] Luu NT, Rainger GE, Buckley CD, Nash GB. CD31 regulates direction and rate of neutrophil migration over and under endothelial cells. J Vasc Res. 2003; 40:467-479. [91] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362:801-809. [92] Osterud B, Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev. 2003; 83:1069-1112. [93] Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens. 2001; 14:44S-54S. [94] Hope SA, Meredith IT. Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J. 2003; 33:380-386. [95] Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol. 2004; 24:1997-2008. [96] Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Yan ZQ, Weber C. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res. 2004; 94:776-784. [97] Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor beta is produced by co-cultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A. 1989; 86:4544-4548. [98] Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 1998; 141:805-814. [99] Asakawa H, Kobayashi T. The effect of co-culture with human smooth muscle cells on the proliferation, the IL-1 beta secretion, the PDGF production and tube formation of human aortic endothelial cells. Cell Biochem Funct. 1999; 17:123-130. [100] Kang YH, Brummel SE, Lee CH. Differential effects of transforming growth factor-beta 1 on lipopolysaccharide induction of endothelial adhesion molecules. Shock. 1996; 6:118-125. [101] Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998; 18:842-851. [102] Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998; 2:275-281. [103] Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998; 394:894-897. [104] Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 1998; 101:353-363. [105] Zernecke A, Weber KS, Erwig LP, Kluth DC, Schroppel B, Rees AJ, Weber C. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis. J Immunol. 2001; 166:5755-5762. [106] Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol. 1994; 153:2153-60. [107] Economou EV, Malamitsi-Puchner AV, Pitsavos CP, Kouskouni EE, Magaziotou-Elefsinioti I, Damianaki-Uranou D, Stefanadis CI, Creatsas G. Negative association between circulating total homocysteine and proinflammatory chemokines MCP-1 and RANTES in prepubertal lean, but not in obese, children. J Cardiovasc Pharmacol. 2004; 44:310-315. [108] Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest. 1999; 104:1041-1050. [109] Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002; 168:3195-3204. [110] Hensbergen PJ, Wijnands PG, Schreurs MW, Scheper RJ, Willemze R, Tensen CP. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis. J Immunother. 2005; 28:343-351. [111] Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993; 177:1809-1814. [112] Jinquan T, Frydenberg J, Mukaida N, Bonde J, Larsen CG, Matsushima K, Thestrup-Pedersen K. Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. J Immunol. 1995; 155:5359-5368. [113] Roth SJ, Carr MW, Springer TA. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol. 1995; 25:3482-3488. [114] Mano T, Luo Z, Malendowicz SL, Evans T, Walsh K. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res. 1999; 84:647-654. [115] Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN. Overexpression of transforming growth factor [beta]1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci USA. 1998; 95:6983-6988. [116] Rekhter MD, Simari RD, Work CW, Nabel GJ, Nabel EG, Gordon D. Gene transfer into normal and atherosclerotic human blood vessels. Circ Res. 1998; 82:1243-1252. [117] Ulbrich H, Eriksson EE, Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci. 2003; 24:640-647. [118] Etzioni A, Doerschuk CM, Harlan JM. Of man and mouse: leukocyte and endothelial adhesion molecule deficiencies. Blood. 1999; 94:3281-3288. [119] Mason, J.C. Statins and their role in vascular protection. Clin. Sci. 2003; 105:251-266. [120] Tham DM, Wang YX, Rutledge JC. Modulation of vascular inflammation by PPARs. Drug News Perspect. 2003; 16:109-116. [121] Eriksson EE, Werr J, Guo Y. Direct observations in vivo on the role of endothelial selectins and alpha(4) integrin in cytokine-induced leukocyte endothelium interactions in the mouse aorta. Circ Res. 2000; 86:526-533. [122] Ramos CL, Huo Y, Jung U. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999; 84:1237-1244. [123] Lusis AJ. Atherosclerosis. Nature. 2000; 407:233-241. [124] Robertson AK, Rudling M, Zhou X. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest. 2003; 112:1342-1350. [125] Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest. 2002; 109:745-753. [126] Mallat Z, Gojova A, Brun V. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E knockout mice. Circulation. 2003; 108:1232-1237. [127] Laine P, Kaartinen M, Penttila A. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999; 99:361-369. [128] Tupin E, Nicoletti A, Elhage R. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med. 2004; 199:417-422. [129] Naruko T, Ueda M, Haze K. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002; 106:2894-2900.
|